We deliberated earlier that co-drug Bet-CA, a metabolic modulator, exhibits antineoplastic activity both in vitro and in vivo against several cancers and is particularly attractive because of its milder toxicity profile and therefore has a theoretical advantage as a chemosensitizer. Here, DNER is linked to cancer.